Search research articles
Contact Us
Filters
Showing results (61-70 of 116) with videos related to
Page
of 12
Sort By:
Cancer Cell
|
December 16, 2011
Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia
Leisl M Packer, Sareena Rana, Robert Hayward, et al.
Cancer Research
|
July 24, 2021
Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations
Paul Yenerall, Rahul K Kollipara, Kimberley Avila, et al.
Oncogene
|
August 12, 2014
Functional RNAi screen targeting cytokine and growth factor receptors reveals oncorequisite role for interleukin-2 gamma receptor in JAK3-mutation-positive leukemia
A Agarwal, R J MacKenzie, C A Eide, et al.
Blood
|
December 17, 2008
High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients
Jeffrey W Tyner, Heidi Erickson, Michael W N Deininger, et al.
Advances in Radiation Oncology
|
June 16, 2018
Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapy
Hanne A Eide, Ingerid Skjei Knudtsen, Vandana Sandhu, et al.
Diabetologia
|
August 23, 2014
In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney alone
Jørn P Lindahl, Finn P Reinholt, Ivar A Eide, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation
|
November 18, 2017
Development of Kidney Transplant Fibrosis Is Inversely Associated With Plasma Marine Fatty Acid Level
Ivar A Eide, Christina Dörje, My Svensson, et al.
Science Translational Medicine
|
September 5, 2014
A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia
Leyuan Ma, Yi Shan, Robert Bai, et al.
Science Signaling
|
July 19, 2018
Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemia
Chelsea Jenkins, Samuel B Luty, Julia E Maxson, et al.
Cancer Research
|
June 3, 2015
Therapeutically Targetable ALK Mutations in Leukemia
Julia E Maxson, Monika A Davare, Samuel B Luty, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 116) with videos related to
Sort By:
Page
of 12
Cancer Cell
|
December 16, 2011
Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia
Leisl M Packer, Sareena Rana, Robert Hayward, et al.
Cancer Research
|
July 24, 2021
Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations
Paul Yenerall, Rahul K Kollipara, Kimberley Avila, et al.
Oncogene
|
August 12, 2014
Functional RNAi screen targeting cytokine and growth factor receptors reveals oncorequisite role for interleukin-2 gamma receptor in JAK3-mutation-positive leukemia
A Agarwal, R J MacKenzie, C A Eide, et al.
Blood
|
December 17, 2008
High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients
Jeffrey W Tyner, Heidi Erickson, Michael W N Deininger, et al.
Advances in Radiation Oncology
|
June 16, 2018
Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapy
Hanne A Eide, Ingerid Skjei Knudtsen, Vandana Sandhu, et al.
Diabetologia
|
August 23, 2014
In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney alone
Jørn P Lindahl, Finn P Reinholt, Ivar A Eide, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation
|
November 18, 2017
Development of Kidney Transplant Fibrosis Is Inversely Associated With Plasma Marine Fatty Acid Level
Ivar A Eide, Christina Dörje, My Svensson, et al.
Science Translational Medicine
|
September 5, 2014
A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia
Leyuan Ma, Yi Shan, Robert Bai, et al.
Science Signaling
|
July 19, 2018
Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemia
Chelsea Jenkins, Samuel B Luty, Julia E Maxson, et al.
Cancer Research
|
June 3, 2015
Therapeutically Targetable ALK Mutations in Leukemia
Julia E Maxson, Monika A Davare, Samuel B Luty, et al.
Page
of 12